AntimetabolitesAntimetabolites, AntineoplasticLeukemia, Hairy CellTetrahydrouridineFloxuridineTrabeculectomyInosine MonophosphatePhosphoribosyl PyrophosphateAntineoplastic AgentsPentostatinFluorouracilCytarabineMitomycin6-MercaptopurineMethotrexateLeukemia L1210Folic Acid AntagonistsArabinonucleosidesDrug Screening Assays, AntitumorPurinesLeukemia, Lymphocytic, Chronic, B-CellDrug SynergismAminosalicylic AcidsVidarabineRemission InductionDeoxycytidineLeukemia, ProlymphocyticDrug Evaluation, PreclinicalCell SurvivalTumor Cells, CulturedNeoplasmsChlorambucilDrug Administration ScheduleCell CycleCell DivisionWaldenstrom MacroglobulinemiaPolandSplenectomy2-ChloroadenosineInfusions, IntravenousCell LineRetreatmentAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsKineticsAdenine NucleotidesBenzenesulfonatesDaunorubicinCyclophosphamideTreatment OutcomeLymphoma, Non-HodgkinRecurrencePrednisoneNeoplasm, ResidualCladribineNeutropeniaInhibitory Concentration 50